Suppr超能文献

卵巢癌手术严重并发症的危险因素。

Risk Factors for Severe Complications in Ovarian Cancer Surgery.

机构信息

Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany

Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany.

出版信息

In Vivo. 2020 Nov-Dec;34(6):3361-3365. doi: 10.21873/invivo.12174.

Abstract

UNLABELLED

Backround: Due to extensive surgical intervention for macroscopic complete cytoreduction in epithelial ovarian cancer (EOC) patients, severe complications in the postoperative course are possible.

PATIENTS AND METHODS

A total of 345 EOC patients who underwent cytoreductive surgery were retrospectively evaluated regarding risk factors for an unfavorable postoperative course. Possible pre-, intra- and postoperative risk factors were statistically analyzed performing multivariate ordinal logistic regression.

RESULTS

A total of 345 EOC patients underwent cytoreductive surgery. There were no complications in 114 patients, mild complications in 114 patients and severe complications in 117 patients. The risk factor evaluation identified age (p=0.049), smoking (p=0.032) and duration of surgery (p<0.0001) as significant factors for severe postoperative morbidity.

CONCLUSION

In EOC patients age, smoking and the duration of surgery have significant impact on the postoperative course. Only the duration of surgery can be positively influenced by a well-trained EOC team.

摘要

背景

由于上皮性卵巢癌(EOC)患者需要进行广泛的外科手术以实现宏观完全减瘤,因此术后可能会出现严重并发症。

患者和方法

回顾性评估了 345 例接受细胞减灭术的 EOC 患者,以评估术后不良病程的危险因素。通过多变量有序逻辑回归对可能的术前、术中和术后危险因素进行统计学分析。

结果

共 345 例 EOC 患者接受了细胞减灭术。114 例患者无并发症,114 例患者有轻度并发症,117 例患者有重度并发症。风险因素评估确定年龄(p=0.049)、吸烟(p=0.032)和手术持续时间(p<0.0001)是重度术后发病率的显著因素。

结论

在 EOC 患者中,年龄、吸烟和手术持续时间对术后病程有显著影响。只有手术持续时间可以通过训练有素的 EOC 团队得到积极影响。

相似文献

1
Risk Factors for Severe Complications in Ovarian Cancer Surgery.
In Vivo. 2020 Nov-Dec;34(6):3361-3365. doi: 10.21873/invivo.12174.
2
Perioperative fluid balance and major postoperative complications in surgery for advanced epithelial ovarian cancer.
Gynecol Oncol. 2021 May;161(2):402-407. doi: 10.1016/j.ygyno.2021.02.034. Epub 2021 Mar 12.
3
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective study.
Gynecol Oncol. 2017 Oct;147(1):66-72. doi: 10.1016/j.ygyno.2017.07.008. Epub 2017 Jul 15.
4
[Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
Zhonghua Fu Chan Ke Za Zhi. 2016 May 25;51(5):361-5. doi: 10.3760/cma.j.issn.0529-567X.2016.05.008.
6
Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.
Eur J Surg Oncol. 2020 May;46(5):855-861. doi: 10.1016/j.ejso.2020.01.026. Epub 2020 Jan 20.
8
Complications and Survivorship Trends After Primary Debulking Surgery for Ovarian Cancer.
J Surg Res. 2020 Feb;246:34-41. doi: 10.1016/j.jss.2019.08.027. Epub 2019 Sep 24.

引用本文的文献

1
Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery.
Ann Surg Oncol. 2024 Dec;31(13):8944-8951. doi: 10.1245/s10434-024-16246-0. Epub 2024 Oct 8.
2
Postoperative Complications of Upfront Ovarian Cancer Surgery and Their Effects on Chemotherapy Delay.
Curr Oncol. 2024 Sep 19;31(9):5630-5642. doi: 10.3390/curroncol31090417.
4
Predicting incomplete cytoreduction in patients with advanced ovarian cancer.
Front Oncol. 2022 Dec 15;12:1060006. doi: 10.3389/fonc.2022.1060006. eCollection 2022.
5
Postoperative paralytic ileus following debulking surgery in ovarian cancer patients.
Front Surg. 2022 Aug 24;9:976497. doi: 10.3389/fsurg.2022.976497. eCollection 2022.
6
Impact of Obesity on Major Surgical Outcomes in Ovarian Cancer: A Meta-Analysis.
Front Oncol. 2022 Feb 9;12:841306. doi: 10.3389/fonc.2022.841306. eCollection 2022.

本文引用的文献

1
Prevention of Anastomotic Leakage in Ovarian Cancer Debulking Surgery and Its Impact on Overall Survival.
Anticancer Res. 2019 Sep;39(9):5209-5218. doi: 10.21873/anticanres.13718.
2
Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.
Am J Obstet Gynecol. 2019 Jun;220(6):571.e1-571.e8. doi: 10.1016/j.ajog.2019.02.019. Epub 2019 Feb 13.
3
The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery.
Gynecol Oncol. 2017 Sep;146(3):498-503. doi: 10.1016/j.ygyno.2017.06.007. Epub 2017 Jun 10.
4
Unplanned reoperations after vascular surgery.
J Vasc Surg. 2016 Mar;63(3):730-6. doi: 10.1016/j.jvs.2015.09.046. Epub 2015 Nov 6.
5
Surgical morbidity and clinical outcomes in ovarian cancer - the role of obesity.
BJOG. 2016 Jan;123(2):300-8. doi: 10.1111/1471-0528.13585.
6
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.
Br J Cancer. 2015 Sep 1;113(5):817-26. doi: 10.1038/bjc.2015.245. Epub 2015 Jul 7.
7
How slow is too slow? Correlation of operative time to complications: an analysis from the Tennessee Surgical Quality Collaborative.
J Am Coll Surg. 2015 Apr;220(4):550-8. doi: 10.1016/j.jamcollsurg.2014.12.040. Epub 2015 Jan 9.
8
Prognostic significance of Sugarbaker's peritoneal cancer index for the operability of ovarian carcinoma.
Int J Gynecol Cancer. 2015 Jan;25(1):135-44. doi: 10.1097/IGC.0000000000000327.
9
Development and assessment of Memorial Sloan Kettering Cancer Center's Surgical Secondary Events grading system.
Ann Surg Oncol. 2015 Apr;22(4):1061-7. doi: 10.1245/s10434-014-4141-4. Epub 2014 Oct 16.
10
Impact of obesity on surgical and oncologic outcomes in ovarian cancer.
Gynecol Oncol. 2014 Oct;135(1):19-24. doi: 10.1016/j.ygyno.2014.07.103. Epub 2014 Aug 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验